title: [Tumors of the bladder in women. Epidemiologic and therapeutic aspects. Apropos of 40 cases].
abstract: Bladder tumours in women. Epidemiological aspects and treatments, based on a series of 48 cases. Bladder tumours are more frequent in men than in women, in whom they present certain epidemiological, clinical and therapeutic characteristics. The authors report a retrospective study of 48 cases of bladder tumour in women, observed in the urology department over a 20-year period. These tumours represented 4.2% of all bladder tumours. The patients had a mean age of 59 years (range: 29 to 77). Only one patient was a smoker (2%). Haematuria was present in 93% of cases, and signs of bladder irritation were present in 60% of cases. All tumours were transitional cell carcinomas. The tumour was classified as stage 0 in 10 cases (20.9%), stage A in 15 patients (31.2%), stage B in 22 patients (45.8%) and stage C in 1 case (2.1%); no patients (0%) were classified as stage D. Our therapeutic protocol was established as a function of the stage of tumour invasion. For example, superficial tumours were treated conservatively by transurethral resection, either alone or combined with intravesical instillation. Radical surgery was performed whenever possible for invasive tumours. External urinary diversion was performed in 11 cases, ureterosigmoidostomy in 3 cases and enterocystoplasty in 5 cases. The clinical course of the 15 superficial tumours was marked by recurrence in 5 cases, while that of the 23 invasive tumours was marked by local recurrence (3 cases), renal failure (1 case) and 3 deaths.
authors.affiliation: Service d'Urologie, CHU Ibn Rochd, Casablanca, Maroc.
authors.forename: R
authors.initials: R
authors.lastname: Rabii
authors.forename: A
authors.initials: A
authors.lastname: el Moussaoui
authors.forename: H
authors.initials: H
authors.lastname: Rais
authors.forename: A
authors.initials: A
authors.lastname: Joual
authors.forename: A
authors.initials: A
authors.lastname: Debbagh
authors.forename: M
authors.initials: M
authors.lastname: el Mrini
authors.forename: S
authors.initials: S
authors.lastname: Benjelloun
mesh_terms: D000283:Administration, Intravesical; D000328:Adult; D000367:Age Factors; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000453:epidemiology* / Q000601:surgery; D002423:Cause of Death; D017024:Chemotherapy, Adjuvant; D012809:Colon, Sigmoid / Q000601:surgery; D003556:Cystitis / Q000453:epidemiology; D005260:Female; D006417:Hematuria / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009018:Morocco / Q000453:epidemiology; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009367:Neoplasm Staging; D051437:Renal Insufficiency / Q000209:etiology; D012189:Retrospective Studies; D012907:Smoking / Q000453:epidemiology; D014513:Ureter / Q000601:surgery; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology* / Q000601:surgery; D014547:Urinary Diversion
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Tumeurs de vessie chez la femme. Aspects épidémiologiques et thérapeutiques. A propos de 48 cas.